Yes, but that is a formality if the company wants to continue development as those results need to be submitted if they want to get approval for their Phase 3 to commence. The point being, Neuren isn't waiting on the FDA for anything at this stage, despite what the posters above have stated.
Ann: Trading Halt, page-218
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.13 |
Change
-0.595(2.87%) |
Mkt cap ! $2.567B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $4.344M | 216.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 615 | $20.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.13 | 139 | 5 |
View Market Depth
| Last trade - 15.50pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |